{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:35:24Z","timestamp":1780104924227,"version":"3.54.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>The leading pathological mechanisms of Alzheimer\u2019s disease (AD) are amyloidosis and chronic inflammation. The study of new therapeutic drugs of the corresponding action, in particular miRNAs and curcominoids, as well as methods for their packaging, is topical. The aim of the work was to study the effect of miR-101 + curcumin in a single liposome in a cellular AD model. AD model was made by incubating a suspension of mononuclear cells with aggregates of beta-amyloid peptide 1\u201340 (A\u03b240) for 1 h. The effect of the subsequent application of liposomal (L) preparations miR-101, curcumin (CUR), and miR-101 + CUR was analyzed over time of 1, 3, 6, and 12 h. A decrease in the level of endogenous A\u03b242 under the influence of L(miR-101 + CUR) was revealed during the entire incubation period (1\u201312 h), the first part of which was overlapped due to inhibition of mRNA<jats:sup>APP<\/jats:sup> translation by miR-101 (1\u20133 h), and the second-by inhibition of mRNA<jats:sup>APP<\/jats:sup> transcription by curcumin (3\u201312 h), the minimum concentration of A\u03b242 was recorded at 6 h. The cumulative effect of the combination drug L(miR-101 + CUR) was manifested in the suppression of the increase in the concentration of TNF\u03b1 and IL-10 and a decrease in the concentration of IL-6 during the entire incubation period (1\u201312 h). Thus, miR-101 + CUR in one liposome enhanced each other\u2019s antiamyloidogenic and anti- inflammatory effects in a cellular AD model.<\/jats:p>","DOI":"10.3389\/fncel.2023.1169980","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:21:13Z","timestamp":1682050873000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The cumulative effect of the combined action of miR-101 and curcumin in a liposome on a model of Alzheimer\u2019s disease in mononuclear cells"],"prefix":"10.3389","volume":"17","author":[{"given":"Victoria Vasilevna","family":"Sokolik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Grigorievna","family":"Berchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.743573","article-title":"MicroRNAs as Potential Orchestrators of Alzheimer\u2019s Disease-Related Pathologies: Insights on Current Status and Future Possibilities.","volume":"13","author":"Abuelezz","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.pbb.2008.09.010","article-title":"Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer\u2019s disease.","volume":"91","author":"Ahmed","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","article-title":"Microglia and Astrocytes in Alzheimer\u2019s Disease: Implications for Therapy.","volume":"16","author":"Fakhoury","year":"2018","journal-title":"Curr. Neuropharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","article-title":"Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.","volume":"102","author":"Garcia-Alloza","year":"2007","journal-title":"J. Neurochem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2174\/1381612822666161006151605","article-title":"Curcumin: An Effective Inhibitor of Interleukin-6.","volume":"23","author":"Ghandadi","year":"2017","journal-title":"Curr. Pharm. Des"},{"key":"B6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","article-title":"Curcumin and Alzheimer\u2019s Disease.","volume":"16","author":"Hamaguchi","year":"2010","journal-title":"CNS Neurosci. Therap."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.071026310","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/\u03b2-secretase expression.","volume":"105","author":"H\u00e9bert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies.","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease.","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci. Transl. Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02652048.2021.2021307","article-title":"The tiny big world of solid lipid nanoparticles and nanostructured lipid carriers: An updated review.","volume":"39","author":"Mageed","year":"2021","journal-title":"J. Microencapsul."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/728983","article-title":"New acetylcholinesterase inhibitors for Alzheimer\u2019s disease.","volume":"2012","author":"Mehta","year":"2012","journal-title":"Int. J. Alzheimers Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer\u2019s disease.","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimer Dement."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008898","article-title":"Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer\u2019s disease cortex reveals altered miRNA regulation.","volume":"5","author":"Nunez-Iglesias","year":"2010","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/jnr.20025","article-title":"Curcumin has potent anti- amyloidogenic effects for Alzheimer\u2019s beta-amyloid fibrils in vitro.","volume":"75","author":"Ono","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0865-9","article-title":"Why does the A\u03b2 peptide of Alzheimer share structural similarity with antimicrobial peptides?","volume":"3","author":"Pastore","year":"2020","journal-title":"Commun. Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/brain\/awaa395","article-title":"Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease.","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.bbrc.2016.08.067","article-title":"A Critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer\u2019s disease.","volume":"483","author":"Reddy","year":"2017","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010113","article-title":"microRNAs as early biomarkers of Alzheimer\u2019s disease: A synaptic perspective.","volume":"10","author":"Siedlecki-Wullich","year":"2021","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.15407\/biotech12.03.041","article-title":"Anti-amyloidogenic Effect of MiR-101 in Experimental Alzheimer\u2019s Disease.","volume":"12","author":"Sokolik","year":"2019","journal-title":"Biotechnol. Acta"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000357","article-title":"Comparative analysis of nasal therapy with soluble and liposomal forms of curcumin on rats with alzheimer\u2019s disease model.","volume":"7","author":"Sokolik","year":"2017","journal-title":"J. Alzheimer Dis. Parkinson."},{"key":"B21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3103\/S0095452721060141","article-title":"Direct and indirect action of liposomal form of MIR-101 on cells in the experimental model of alzheimer\u2019s disease.","volume":"55","author":"Sokolik","year":"2021","journal-title":"Cytol. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15407\/biotech8.06.048","article-title":"Effect of curcumin liposomal form on angiotensin converting activity, cytokines, and cognitive characteristics of the rats with Alzheimer\u2019s disease model.","volume":"8","author":"Sokolik","year":"2015","journal-title":"Biotechnol. Acta"},{"key":"B23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.15407\/ubj88.03.083","article-title":"Effect of curcumin on accumulation in mononuclear cells and secretion in incubation medium of \u00c0\u03b240 and cytokines under local excess of \u00c0\u03b242-homoaggregates.","volume":"88","author":"Sokolik","year":"2016","journal-title":"Ukr. Biochem. J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"18344","DOI":"10.1074\/jbc.M110.112664","article-title":"MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons.","volume":"285","author":"Vilardo","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2023.1169980\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:21:15Z","timestamp":1682050875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2023.1169980\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":24,"alternative-id":["10.3389\/fncel.2023.1169980"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2023.1169980","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"article-number":"1169980"}}